Keyword: Genvec

GenVec: We’re not a victim of Novartis R&D cuts

After the news broke yesterday that Novartis was to cut a slew of workers from its gene and cell therapy programs, this has left many wondering about its broader pacts in this space--and their future. GenVec, which is developing a hearing loss gene therapy with the Swiss major, was quick to say it will not be one of those axed.